Association between chronic kidney disease and mortality in stage IV cancer
- 8 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 25 (9), 1587-1595
- https://doi.org/10.1007/s10147-020-01715-9
Abstract
Background Chronic kidney disease (CKD) is known to be associated with cancer mortality. However, no study has considered the well-known cancer prognostic factors, ECOG Performance Status (PS) and cancer treatment, as confounding factors. We assessed the independent relationship between CKD and cancer death in stage IV cancer patients. Methods In this retrospective observational study, we included stage IV cancer patients diagnosed from 2009 to 2014 in a single center. We collected baseline clinical and laboratory variables, and cancer-specific variables, and assessed the presence of CKD. Our primary outcome was all-cause mortality. The secondary outcome was cancer-specific mortality and site-specific cancer mortality. Results Among 961 eligible stage IV cancer patients (median age 69 years, 51.8% male), 150 patients had CKD. During follow-up (median 9.8 months), 638 patients died, of whom 526 patients died from cancer. After adjusting for prognostic variables, including ECOG PS and cancer treatment, all-cause mortality and cancer-specific mortality were significantly higher in CKD patients than in non-CKD patients (HR 1.41, 95% CI 1.13–1.77 and HR 1.43, 95% CI 1.12–1.83, respectively). In patients with breast and kidney and urinary tract cancers, CKD was associated with a significantly increased risk of death (HR 7.01, 95% CI 1.47–33.4 and HR 3.33, 95% CI 1.42–7.78, respectively). Conclusions CKD at the time of stage IV cancer diagnosis was associated with all-cause mortality and cancer-specific mortality. Moreover, the association between CKD and cancer-specific death was site specific for breast cancer and kidney and urinary tract cancer.Keywords
This publication has 40 references indexed in Scilit:
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet, 2016
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- Simple Prognostic Model for Patients With Advanced Cancer Based on Performance StatusJournal of Oncology Practice, 2014
- Early palliative care for patients with advanced cancer: a cluster-randomised controlled trialThe Lancet, 2014
- Reduced Estimated GFR and Cancer MortalityAmerican Journal of Kidney Diseases, 2014
- Cancer-Specific Mortality in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Cancer and renal insufficiency results of the BIRMA studyBritish Journal of Cancer, 2010
- A History of Cancer ChemotherapyCancer Research, 2008
- Chronic Kidney Disease and Mortality RiskJournal of the American Society of Nephrology, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004